Fate Therapeutics
FATE
#8579
Rank
HK$2.15 B
Marketcap
HK$17.97
Share price
-5.76%
Change (1 day)
63.76%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: HK$2.15 Billion

As of October 2026 Fate Therapeutics has a market cap of HK$2.15 Billion. This makes Fate Therapeutics the world's 8579th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.15 B139.92%
2025HK$0.89 B-36.95%
2024HK$1.42 B-50.57%
2023HK$2.88 B-62.4%
2022HK$7.66 B-82.42%
2021HK$43.56 B-29.16%
2020HK$61.49 B432.81%
2019HK$11.54 B77.58%
2018HK$6.49 B158.66%
2017HK$2.51 B211.95%
2016HK$0.80 B7.39%
2015HK$0.75 B-6.53%
2014HK$0.80 B-19.35%
2013HK$0.99 B

End of Day market cap according to different sources

On Oct 6th, 2026 the market cap of Fate Therapeutics was reported to be:

HK$2.15 Billion
by Nasdaq info icon info icon
HK$2.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
HK$385.41 B 17,798.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$14.34 B 566.35%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$41.72 B 1,837.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$116.07 B 5,290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.28 B 3,999.71%๐Ÿ‡บ๐Ÿ‡ธ USA